NurseJet
Back to Discover
Research ArticleResearchMedication SafetyPatient Education

Targeted vitamin D did not significantly reduce major cardiovascular events after MI

European heart journal (PubMed)Sep 6, 2026

AI-summarized from the linked source. Educational brief, not medical advice.

Brief summary

In the pragmatic TARGET-D randomized trial, vitamin D dosing titrated to a serum target did not significantly reduce the composite of death, recurrent myocardial infarction, heart-failure hospitalization, or stroke after myocardial infarction.

What NurseJet pulled from the source

Among 630 participants followed for an average of 4.2 years, major cardiovascular events occurred in 15.7% with targeted vitamin D management and 18.4% with usual care (hazard ratio 0.85, 95% CI 0.58 to 1.24; P=0.40).

Why this matters for nurses

The trial cautions against presenting targeted vitamin D supplementation as a proven strategy for reducing major cardiovascular events after myocardial infarction.

Bedside takeaway

Present vitamin D as prescribed supplementation, not as a replacement for established post-MI secondary prevention.

Key takeaways

  • At baseline, 87% of participants had a 25-hydroxyvitamin D level of 40 ng/mL or lower.
  • The primary composite outcome and the individual outcomes of death, heart-failure hospitalization, and stroke were not significantly different.
  • A lower recurrent-MI rate was a secondary finding and should not override the nonsignificant primary result.

Practice implications

  • Reinforce the prescribed secondary-prevention plan and avoid implying that vitamin D replaces therapies with established post-MI benefit.

Limitations & cautions

  • Abstract-only summary. The trial included 630 participants, 78.1% were men, the primary confidence interval included benefit and no benefit, and individual secondary outcomes were not the primary endpoint.
  • AI-summarized from the linked source. Review the original article before applying to practice.

Citations

Exact source links

Public citations are filtered to exact credible source pages. Homepage-only or invalid links stay in admin review and are not shown here.

European heart journal (PubMed)

European heart journal (PubMed). Targeted vitamin D supplementation and major adverse cardiovascular events after myocardial infarction: the TARGET-D trial.

Open original source

https://pubmed.ncbi.nlm.nih.gov/42702500/

Professional education only

This summary does not replace clinical judgment, facility policy, provider orders, or official guidelines. Verify practice changes against the original source and local protocol.

Related briefs

More updates for this clinical area

Back to Discover

Renal failure (PubMed)

A single-center retrospective cohort found that approximately one quarter of laboratory-defined acute kidney injury cases on internal medicine wards were not documented, particularly when maximal creatinine was lower.

Med-SurgAI summaryReview source

Journal of neurology (PubMed)

A cumulative meta-analysis found longer survival over time in Duchenne muscular dystrophy, alongside a shift from predominantly respiratory toward cardiac causes of death.

PedsICUAI summaryReview source

Journal of the American Medical Directors Association (PubMed)

A prospective Dutch nursing-home cohort found clinically important differences in illness burden across respiratory viruses, with influenza and human metapneumovirus standing out.

GeriatricsMed-SurgAI summaryReview source